Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient

Therapy with an IL-15 superagonist resulted in immune and clinical responses in a transplant recipient with PML.

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Oza, Aabha, Rettig, Michael P., Powell, Phil, O’Brien, Kathryn, Clifford, David B., Ritchey, Julie, Gehrs, Leah, Hollaway, Julia, Major, Eugene, Fehniger, Todd A., Miller, Christopher A., Soon-Shiong, Patrick, Rock, Amy, DiPersio, John F.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Exceptional Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284083/
https://ncbi.nlm.nih.gov/pubmed/32484854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000664
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars